🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the effects of the eNOS activat...
Status
Completed
Location
University of Basel, Division of Cognitive Neuroscience
Start Date
2015-01
Trial ID
NCT02321852
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The purpose of the validation study is to develop a valid test battery for ...
Status
Completed
Location
SINTEF Health and Research
Start Date
2009-09
Trial ID
NCT00967421
Treatments Being Tested
This randomized clinical study was designed to compare two pain treatment a...
Status
Enrolling By Invitation
Location
Mayo Hospital, Lahore
Start Date
2026-02-01
Trial ID
NCT07606638
Treatments Being Tested
This study investigates the impact of perioperative inhibition of beta-adre...
Status
Recruiting
Location
The Chaim Sheba Medical Center
Start Date
2025-03-12
Trial ID
NCT06839144
The goal of this study is to assess a slimy substance that settles/deposits...
Status
Terminated
Location
Emory University
Start Date
2014-04
Trial ID
NCT02114697
Treatments Being Tested
This study is a double-blind, placebo-controlled randomized clinical trial ...
Status
Completed
Location
UCLA Addictions Laboratory
Start Date
2018-10-01
Trial ID
NCT03594435
Treatments Being Tested
The objective of this trial is to examine the effect of immediate versus la...
Status
Recruiting
Location
Sahlgrenska University Hospital
Start Date
2025-01-06
Trial ID
NCT06562582
Treatments Being Tested
ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-05-08
Trial ID
NCT04401579
Treatments Being Tested